Erythema Multiforme-Like Drug Eruption Associated With Adalimumab Treatment

Dermatitis®Ahead of Print LettersErythema Multiforme-Like Drug Eruption Associated With Adalimumab TreatmentMingjun Lei, Ruiju Niu, Xiumei Cheng, Xiaoyun Zhang, Sisi Xue, and Yinan YangMingjun LeiDepartment of Dermatology, Hebei Traditional Chinese Medical Hospital, Shijiazhuang City, Hebei Province, China.Search for more papers by this author, Ruiju NiuDepartment of Dermatology, Zanhuang County Hospital, Shijiazhuang City, Hebei Province, China.Search for more papers by this author, Xiumei ChengHebei University of Chinese Medicine, Shijiazhuang City, Hebei Province, China.Search for more papers by this author, Xiaoyun ZhangHebei University of Chinese Medicine, Shijiazhuang City, Hebei Province, China.Search for more papers by this author, Sisi XueHebei University of Chinese Medicine, Shijiazhuang City, Hebei Province, China.Search for more papers by this author, and Yinan YangE-mail Address: [email protected]College of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang City, Hebei Province, China.Search for more papers by this authorPublished Online:17 Aug 2023https://doi.org/10.1089/derm.2023.0110AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Erythema Multiforme-Like Drug Eruption Associated With Adalimumab Treatment." Dermatitis®, , pp. FiguresReferencesRelatedDetails Volume 0Issue 0 Information© 2023 American Contact Dermatitis Society. All Rights Reserved.To cite this article:Mingjun Lei, Ruiju Niu, Xiumei Cheng, Xiaoyun Zhang, Sisi Xue, and Yinan Yang.Erythema Multiforme-Like Drug Eruption Associated With Adalimumab Treatment.Dermatitis®.ahead of printhttp://doi.org/10.1089/derm.2023.0110Online Ahead of Print:August 17, 2023PDF download